Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 241 results
A blood sample in a lab setting

Oct 19, 2026

Landmark UK Biobank, IMU Immune Profiling Initiative Taps Ultima and Waters

A groundbreaking collaboration between IMU Biosciences and the UK Biobank aims to create an extensive and detailed map of the human immune system, leveraging advanced technologies and AI methodologies.The initiative seeks to enhance the UK Biobank's existing dataset by adding high-resolution immune data, generating over 100 million immune data points from tens of thousands of samples. This will result in the most comprehensive immune dataset to date. The project utilizes IMU’s HD Immunology plat
Press release cover image

Oct 19, 2026

Helix to Present Three-Year Genomic Screening Outcomes at ASHG 2026 Opening Plenary

Additional studies ranging from GLP-1 to dementia draw on a Helix GenoSphere™ resource that now includes over 620,000 paired EHR + Claims + Genomics records.SAN MATEO, Calif., Oct. 19, 2026 /PRNewswire/ -- Helix, the leading enterprise precision medicine company, will present three-year outcomes from population genomic screening at the opening plenary session of the American Society of Human Genetics 2026 Annual Meeting, taking place October 20-24 in Montreal, Canada.The talk draws on data from
Press release cover image

Oct 19, 2026

23andMe Research Institute to Showcase Scientific Impact and Expanded Research Capabilities at ASHG 2026

New research and capabilities highlight the power of more than 11 million consented research participantsPALO ALTO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- At the American Society of Human Genetics (ASHG) 2026 Annual Meeting, taking place October 20–24 in Montréal, 23andMe Research Institute will present new research demonstrating how its more than 11 million consented research participants are enabling scientific discoveries and advancing the understanding of human health. The nonprofit will
Press release cover image

Oct 19, 2026

PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI

MENLO PARK, Calif. and DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Verily Health Inc., a healthcare data intelligence company, announced today a multi-year strategic collaboration to integrate PacBio HiFi sequencing with Verily Health’s governed data and AI platform. The collaboration will link PacBio sequencing workflows to Verily Pre, combining long-read genomic data with real-world clinical data at popu
Press release cover image

Oct 19, 2026

Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection

New campaign connects AI-powered performance insights linking advanced molecular intelligence to help detect cancer in earlier stagesIRVING, Texas, Oct. 19, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the launch of the second commercial in a series promoting Caris Detect™, Caris' multi-cancer early detection (MCED) test, featuring three-time major champion professional golfer, Jordan Spieth.The campaign emphasizes that while modern technolo
Press release cover image

Oct 19, 2026

ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology

Natera and its collaborators will present 20 abstracts, including 4 rapid oral presentationsSignatera™ Genome with Phased and Structural Variants, which has achieved detection below 1 part per 10 million and an LOD95 of 1 part per million, will be featured in Natera’s ESMO programAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts featuring its technology will be presented at the 2026 European Soc
Press release cover image

Oct 16, 2026

Human Longevity Expands Its $1 Million Cancer Prevention Pledge to Breast Cancer

Breast Cancer Awareness Month initiative supports early detection and eligible members diagnosed with stage IV diseaseSAN FRANCISCO, Oct. 16, 2026 /PRNewswire/ -- Human Longevity, Inc. (HLI) today expanded its $1 million Cancer Prevention Pledge to breast cancer, providing up to $1 million in treatment and clinical support for eligible members diagnosed with stage IV breast cancer, subject to program terms."We are so confident in our integrated detection approach that we believe no member under
Press release cover image

Oct 16, 2026

Nabsys Launches RepX™ for Repeat Expansion Analysis Ahead of ASHG 2026

New pipeline offers the potential to analyze up to 23 disease-associated repeat expansion loci in a single, low-cost runPROVIDENCE, R.I., Oct. 15, 2026 /PRNewswire/ -- Nabsys 2.0, LLC ("Nabsys") today announced the release of RepX™, a repeat expansion analysis pipeline available through its Nabsys Navigator™ cloud platform. RepX uses Electronic Genome Mapping (EGM) data generated on the OhmX™ Platform to investigate disease-associated repeat expansions.Repeat expansions are associated with numer
Minimalist illustration of a microexon and brain tissue

Oct 15, 2026

Newly Identified Microexons Offer Clues to Autism Spectrum Disorder’s Genetic Roots

Recent research highlights the significance of newly identified microexons in understanding the genetic underpinnings of autism spectrum disorder (ASD).Collaborative efforts from institutions such as the University of Toronto and the Sloan Kettering Institute have unveiled hundreds of microexons potentially linked to ASD and other neurological disorders. Published in *Nature*, the study utilized a computational tool named MicroExonator to sift through vast RNA sequencing datasets, leading to the
A tissue sample on a lab bench with a microscope in the background.

Oct 15, 2026

Illumina Combines Multiomics Informatics Applications in New BioInsight Platform

Illumina has introduced the BioInsight platform, a comprehensive software environment designed to enhance the analysis of multiomics datasets, ahead of the 2026 ASHG meeting.The BioInsight platform aims to streamline access to Illumina’s suite of analysis tools, artificial intelligence applications, and curated data resources, allowing scientists to extract actionable insights more efficiently. This initiative stems from Illumina's recognition of a need for improved analytical capabilities to ma
Press release cover image

Oct 15, 2026

Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection

Existing Sputum Sample-Preparation Technology Provides Potential Foundation for Plague DiagnosticsDraws on Rapid-Response Experience with COVID-19, Mpox and Ebola Supported by Expanded Manufacturing InfrastructureSALT LAKE CITY, Oct. 15, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today highlighted capabilities of its Co-Dx PCR Pro®* point-o
Press release cover image

Oct 15, 2026

Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay

HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced the publication of its study "Diagnostic Yield of Genome Sequencing for Children with Intellectual Disability and Developmental Delay (ID/DD)” in Frontiers in Neurology. This study assessed the ability of Baylor Genetics’ Whole Genome Sequencing (WGS) test to identify diagnoses for pediatric patients wi